Medication | Addiction Professional Magazine Skip to content Skip to navigation

Medication

Pharma ready to share if it helps beat the opioid crisis

September 18, 2017  |  Julie Miller, Editor in Chief
article
A public-private partnership will advance new choices for medication assisted treatment for those with opioid use disorders as well as non-addictive drugs for pain.

Drug similar to naltrexone shows promise in early research

September 18, 2017  |  Gary A. Enos, Editor
article
Research on mice leads to speculation that a drug similar to naltrexone could eventually help to prevent alcohol dependence in young drinkers.

Report suggests aggressive health initiative to improve New Jersey reentry outcomes

September 11, 2017  |  Gary A. Enos, Editor
article
Intensive case management with elements of trauma-informed care and harm reduction would improve substance use outcomes for New Jersey inmates reintegrating into the community, a new report suggests.

Opioid treatment programs growing, and expanding into other medications

August 23, 2017  |  Gary A. Enos, Editor
news
Today's opioid treatment programs (OTPs) are increasingly likely to be offering buprenorphine and injectable naltrexone treatment in addition to methadone.

NCAD: Doctor attacks misconceptions about opioid addiction medications

August 20, 2017  |  Gary A. Enos, Editor
article
The owner of Addiction Recovery Resources in Louisiana discussed why it makes sense to integrate 12-Step and medication approaches to opioid addiction treatment.

Stigma apparent in physician replies to survey on buprenorphine prescribing

August 8, 2017  |  Gary A. Enos, Editor
article
A 2016 physician survey on the prescribing of buprenorphine does indicate that counselors and other specialty providers could help physicians overcome reluctance to prescribe the opioid dependence treatment.

Massachusetts case complicates decision-making on workplace marijuana testing

August 1, 2017  |  Gary A. Enos, Editor
article
The business community nationally is closely watching a Massachusetts case in which the state's highest court has affirmed an employee's right to use marijuana for medical purposes.

Three keys to lowering mortality rates in opioid disorder patients

July 21, 2017  |  Alison Knopf, Contributing Writer
article
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.

ADHD patients' substance use risk lower in medicated periods

July 17, 2017  |  Gary A. Enos, Editor
news
Researchers have found that individuals with attention-deficit/hyperactivity disorder (ADHD) are at lower risk of alcohol or drug abuse when they are taking ADHD medications.

Partnership in R.I. will accelerate buprenorphine training

July 13, 2017  |  Gary A. Enos, Editor
article
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.

Outstanding Clinical Care Award: Stanley Street Treatment and Resources Opioid Triage Center

July 12, 2017  |  Gary A. Enos, Editor
article
Individuals affected by the opioid crisis are benefiting from an expansion of SSTAR's open-access model of service.

Drug maker agrees to stop selling Opana ER because of misuse

July 7, 2017  |  Julie Miller, Editor in Chief
news
Endo Pharmaceuticals on Thursday agreed to remove its long-acting Opana ER pain drug from the market, following an FDA request that it stop selling the product because of incidents of misuse.

Pages

Subscribe to Medication